Skip to content
Aperlena
Free alerts

Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) verified 1 week ago Contract notice

Inquiry LERCAN/6/PR 138141/2026-90231-293537 for a bioequivalence study comparing the Test Product and the Reference Product in healthy volunteers

Original ZAPYTANIE OFERTOWE LERCAN/6/PR 138141/2026-90231-293537 Zakup usługi badań biorównoważności w celu porównania biodostępności oraz oceny bezpieczeństwa i tolerancji Produktu Testowanego z Produktem Referencyjnym u zdrowych ochotników. OFFER INQUIRY LERCAN/6/PR 138141/ 2026-90231-293537 Purchase of a bioequivalence study service aimed at comparing bioavailability and assessing the safety and tolerability of the Test Product versus the Reference Product in healthy volunteers.

Open Poland Research & development

Buyer Zakłady Farmaceutyczne Polpharma SA

19 days left

Key facts

Closes
23:59 (UTC+1)
  1. Published
  2. Today
  3. Deadline open for 33 days
  4. Awarded pending

Bidding window

32 days from publication to deadline

Longer than usual

Notices of this kind (Poland, below the EU threshold) give a median of 12 days, half of them between 8 and 15 days, based on 95,282 notices of the last two years.

View the official notice Watch this tender
Add to calendar

If the deadline moves or the notice is corrected, we email you. Log in

Summary

Machine-generated summary

The buyer seeks a service provider to carry out a bioequivalence study comparing bioavailability and assessing the safety and tolerability of a Test Product against a Reference Product in healthy volunteers. The purchase falls under the project FENG.01.01-IP.01-A0ST/24, aimed at developing an innovative, complex two-component medicinal product for the treatment of arterial hypertension. The inquiry is organised as Part 1: Bioequivalence studies. Classified under CPV codes for research and experimental development services. The detailed description of the subject in Appendix No. 2 is protected as a business secret and is disclosed only after signing the non-disclosure agreement attached as Appendix No. 3.

Key points

Reference
2026-90231-293537
Projekt: FENG.01.01-IP.01-A0ST/24 - Opracowanie i rozwój innowacyjnego rozwiązania - złożonego, dwuskładnikowego produktu leczniczego, ukierunkowanego na terapię nadciśnienia tętniczego. Część 1: Badania biorównoważności. / Bioequivalence studies. ZAPYTANIE OFERTOWE LERCAN/6/PR 138141/ 2026-90231-293537 na zakup usługi badań biorównoważności w celu porównania biodostępności oraz oceny bezpieczeństwa i tolerancji Produktu Testowanego z Produktem Referencyjnym u zdrowych ochotników. 3.5. Szczegółowy opis przedmiotu zamówienia określony w ZAŁĄCZNIKU NR 2 jest objęty ochroną tajemnicy przedsiębiorstwa w rozumieniu przepisów ustawy z dnia 16 kwietnia 1993 r. o zwalczaniu nieuczciwej konkurencji (Dz. U. z 2022 r. poz. 1233, z późn. zm.) i jego przekazanie wymaga zawarcia stosownej umowy o zachowaniu poufności (ang. Non-Disclosure Agreement, NDA), stanowiącej ZAŁĄCZNIK NR 3 do niniejszego zapytania ofertowego. OFFER INQUIRY LERCAN/6/PR 138141/2026-90231-293537 for the purchase of a bioequivalence study service aimed at comparing bioavailability and assessing the safety and tolerability of the Test Product versus the Reference Product in healthy volunteers. The detailed description of the subject of the contract, specified in APPENDIX No. 2, constitutes a business secret within the meaning of the Act of 16 April 1993 on Combating Unfair Competition (Journal of Laws of 2022, item 1233, as amended). Disclosure of Appendix No. 2 requires execution of an appropriate Non Disclosure Agreement (NDA), constituting APPENDIX No. 3 to this Request for Quotation. Źródło: Ministerstwo Funduszy i Polityki Regionalnej, Baza Konkurencyjności Funduszy Europejskich; pobrano 2026-10-01; dane przetworzone.
Original text
Numer ogłoszenia: 2026-90231-293537 Projekt: FENG.01.01-IP.01-A0ST/24 - Opracowanie i rozwój innowacyjnego rozwiązania - złożonego, dwuskładnikowego produktu leczniczego, ukierunkowanego na terapię nadciśnienia tętniczego. Część 1: Badania biorównoważności. / Bioequivalence studies. ZAPYTANIE OFERTOWE LERCAN/6/PR 138141/ 2026-90231-293537 na zakup usługi badań biorównoważności w celu porównania biodostępności oraz oceny bezpieczeństwa i tolerancji Produktu Testowanego z Produktem Referencyjnym u zdrowych ochotników. 3.5. Szczegółowy opis przedmiotu zamówienia określony w ZAŁĄCZNIKU NR 2 jest objęty ochroną tajemnicy przedsiębiorstwa w rozumieniu przepisów ustawy z dnia 16 kwietnia 1993 r. o zwalczaniu nieuczciwej konkurencji (Dz. U. z 2022 r. poz. 1233, z późn. zm.) i jego przekazanie wymaga zawarcia stosownej umowy o zachowaniu poufności (ang. Non-Disclosure Agreement, NDA), stanowiącej ZAŁĄCZNIK NR 3 do niniejszego zapytania ofertowego. OFFER INQUIRY LERCAN/6/PR 138141/2026-90231-293537 for the purchase of a bioequivalence study service aimed at comparing bioavailability and assessing the safety and tolerability of the Test Product versus the Reference Product in healthy volunteers. The detailed description of the subject of the contract, specified in APPENDIX No. 2, constitutes a business secret within the meaning of the Act of 16 April 1993 on Combating Unfair Competition (Journal of Laws of 2022, item 1233, as amended). Disclosure of Appendix No. 2 requires execution of an appropriate Non Disclosure Agreement (NDA), constituting APPENDIX No. 3 to this Request for Quotation. CPV: 73000000-2 Usługi badawcze i eksperymentalno-rozwojowe oraz pokrewne usługi doradcze; 73120000-9 Usługi eksperymentalno-rozwojowe Źródło: Ministerstwo Funduszy i Polityki Regionalnej, Baza Konkurencyjności Funduszy Europejskich; pobrano 2026-10-01; dane przetworzone.

Bid or no-bid?

Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.

  1. Your call:

    Do we meet every eligibility criterion?

    The register holds nothing on this. The official documents will.

  2. Your call:

    Can we deliver this with the team we have?

    The register holds nothing on this. The official documents will.

  3. Your call:

    Do we have two comparable references?

    Comparable work is in Research & development.

  4. In your favour:

    Is the deadline realistic for a proper offer?

    19 days left, 13 of them working days.

  5. Your call:

    Is there a margin at the likely winning price?

    In this country this kind of contract is usually awarded for between €25,123 and €212,906.

  6. Your call:

    Do we know this buyer?

    The buyer has 3 notices in the register and no pattern of winners yet.

Can I bid?

Official source

Source: Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej)

Always verify details on the official notice.

Report an error in this notice

Last verified against Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) 1 week ago

Documents on Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) (Polish)

View the official notice

What this market pays

The buyer has too few awards of its own in this sector, so this is the range of the last 158 awards for Research & development in Poland.

Median award
€77,952
Middle half of past awards
€25,123 to €212,906

Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

The buyer

Full buyer profile

Zakłady Farmaceutyczne Polpharma SA

Poland

notices in the register
3

This buyer has no award history in this sector yet. Usual winners, Research & development - Poland

Company Wins Total awarded Last win
IBC Advisory S.A. 8 €464,647 Jul 2026
EVALU Sp. z o.o. 5 €87,037 Aug 2026
ASM Research Solutions Strategy sp. z o.o. 5 €54,872 Mar 2026
Eurofins OBiKŚ Polska Sp. z o.o. 5 Oct 2026
EU-Consult Sp. z o.o. 4 €198,092 Jul 2026

Based on 284 awards with a linked company profile over the last 2 years.

2 open tenders right now

Market context

Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.

open now in Research & development
438
median open notice
€293,131

Who wins in this market

Many suppliers

Poland · Research & development

different companies won awards here
220
of the awards went to the three most frequent winners
6%
buyers awarded contracts here
134

Based on 284 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
2.3
of those lots received a single tender
33%
of the awards went to companies based in another country
6%
of the tenders came from another country
6%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

Awarded before

Never miss a tender like this

49 new notices in Research & development in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, Research and development services and related consultancy services: an email when new tenders arrive under it, no account needed.

Follow CPV 73000000

Email me the new tenders under this code

Research and development services and related consultancy services (73000000) and every code below it. Only new tenders, never the archive.

No account needed. We email you once to confirm the address, and every alert stops with one click.

19 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language